Peptides
a complete clinical reference, prescribed at Luxbae
A comprehensive directory of 50+ peptides — including GLP-1 receptor agonists for weight management, growth hormone secretagogues, recovery and tissue-repair compounds, and the copper-binding tripeptide behind our signature Glow Fusion protocol. Curated and supervised by Dr. Ernst von Schwarz, MD, PhD.
Signaling molecules, not stimulants
Peptides are short chains of amino acids — typically two to fifty residues — that act as the body’s native messenger system. They bind to specific cell-surface receptors and instruct downstream cascades: tell the pituitary to release growth hormone, tell dermal fibroblasts to deposit collagen, tell appetite-regulating neurons in the hypothalamus to stop firing.
That receptor-specific signaling is what makes prescribed peptides different from supplements. A supplement adds raw material to your bloodstream and hopes for the best. A correctly dosed peptide modulates a single biological pathway with predictable, measurable effects.
At Luxbae, every protocol begins with a complimentary medical consultation, baseline lab work where indicated, and ongoing follow-ups to refine dosing as your physiology responds. We do not sell preset packages. We do not skip labs. Every compound on this directory is prescribed only after a physician has reviewed your history.
Four non-negotiables
MD-Prescribed
Every protocol is written by Dr. Ernst von Schwarz personally, not by a sales rep or template engine. Your prescription reflects your labs, history, and goals.
Pharmacy-Grade Compounding
Every peptide we dispense comes from FDA-registered 503A or 503B compounding pharmacies with certificates of analysis on purity, potency, and sterility.
Lab-Anchored
For hormone-axis and metabolic peptides we draw baseline labs first and re-lab at 6–8 weeks. Dosing decisions are made against your numbers, not vibes.
Continuity of Care
Direct access to your medical team between appointments — for questions, side effects, dosing tweaks, or sequencing around in-spa treatments like Morpheus8 or CO2 resurfacing.
Skin Quality, Glow & Cellular Radiance
Copper-binding tripeptides, pineal tetrapeptides, and melanocortin agonists studied for collagen synthesis, dermal fibroblast activation, skin pigmentation, and post-procedure repair. The category most relevant to Luxbae’s aesthetic clientele and our signature Glow Fusion protocol.
GHK-Cu
Originally isolated from human plasma in 1973. The copper-bound complex modulates over 4,000 genes including those for skin remodeling and antioxidant defense — Luxbae's most-prescribed aesthetic peptide.
GHK-CuEpithalon
Discovered in the 1980s at the St. Petersburg Institute of Bioregulation. Four amino acids hypothesized to upregulate telomerase activity and reset circadian rhythm — an investigational longevity compound.
EpithalonGHK / EpithalonBlend
Layered protocol pairing the dermal-regeneration of GHK-Cu with the telomere-maintenance of Epithalon. Frequently prescribed when patients want surface aesthetics and cellular-age markers addressed in parallel.
GHK / Epithalon BlendGHK / Epi / MOTS-cBlend
Three-peptide stack combining skin remodeling (GHK-Cu), telomere signaling (Epithalon), and mitochondrial-derived energy modulation (MOTS-c). Our most comprehensive aesthetic-longevity prescription.
GHK / Epi / MOTS-c BlendMelanotan-2
Synthetic analogue of alpha-melanocyte-stimulating hormone. Binds MC1R for pigment production and MC4R for centrally-mediated arousal. Prescribed selectively; not appropriate for every patient profile.
Melanotan-2The Growth Hormone Axis & Senescence Frontier
GHRH analogues, ghrelin mimetics, and downstream IGF-1 signalers studied for body composition, sleep depth, recovery, and the biological markers of aging. Designed to restore pulsatile growth hormone release rather than override it.
CJC-1295
Modified GHRH with extended half-life via drug-affinity-complex technology. Maintains tonically elevated GH secretion across multi-day windows. The backbone of our growth-hormone protocols.
CJC-1295CJC-1295 / IpamorelinBlend
The two-peptide combination most physicians reach for first. CJC sustains baseline GH; Ipamorelin produces clean pulsatile spikes through ghrelin-receptor activation — mirroring native pituitary patterns.
CJC-1295 / Ipamorelin BlendIpamorelin
A pentapeptide ghrelin mimetic with selective GH-secretagogue activity. Unlike older compounds (GHRP-2, GHRP-6, hexarelin), produces minimal cortisol or prolactin elevation.
IpamorelinIPA / CJC / IGFBlend
Triple-action protocol engaging the entire somatotropic axis: ghrelin-receptor pulses (IPA), sustained GHRH signaling (CJC), and direct IGF-1 receptor agonism. For advanced anti-aging cases.
IPA / CJC / IGF BlendIPA / SermorelinBlend
Short-half-life GHRH (Sermorelin) paired with selective ghrelin mimetic (Ipamorelin). Mirrors physiologic GH pulses without the prolonged elevation of longer GHRH analogues.
IPA / Sermorelin BlendSermorelin
A 29-amino-acid GHRH fragment originally FDA-approved as Geref. Restores native pituitary pulse architecture and has one of the longest clinical safety records in the entire peptide category.
SermorelinTesamorelin
FDA-approved as Egrifta for HIV lipodystrophy. Selectively reduces visceral adipose tissue with documented efficacy in randomized trials (Falutz et al.). Used off-label for body recomposition under MD supervision.
TesamorelinTesa / Ipa / MOTS-cBlend
Combines visceral-fat-targeted GHRH (Tesamorelin), pulsatile GH release (Ipamorelin), and mitochondrial-derived energy signaling (MOTS-c) — a triple-mechanism anti-aging protocol.
Tesa / Ipa / MOTS-c BlendIGF-1 LR3
Long-acting recombinant IGF-1 analogue with extended half-life. The downstream anabolic mediator of GH signaling — drives muscle protein synthesis and satellite-cell activation.
IGF-1 LR3IGF-LR3 / MOTS-cBlend
Anabolic muscle signaling (IGF-1 LR3) combined with mitochondrial biogenesis (MOTS-c). Designed for the patient pursuing strength, recovery, and metabolic flexibility simultaneously.
IGF-LR3 / MOTS-c BlendFOXO4-DRIComing Soon
An investigational FOXO4-binding peptide studied for selective clearance of senescent cells via p53/FOXO4 pathway disruption. Currently in early research at Luxbae — coming soon.
FOXO4-DRIFollistatinComing Soon
Glycoprotein that neutralizes circulating myostatin, releasing the natural inhibition on muscle hypertrophy. Advanced and experimental; reserved for closely-monitored cases — coming soon.
FollistatinHealing Acceleration & Post-Procedure Repair
BPC-157, Thymosin Beta-4, cathelicidin antimicrobials, and synergistic stacks studied for angiogenesis, tendon and ligament repair, GI lining integrity, and post-procedure healing. Especially relevant before and after Morpheus8, CO2 resurfacing, microneedling, and PRP.
BPC-157
Originally isolated from human gastric juice (BPC = Body Protection Compound). Sikiric and colleagues at the University of Zagreb have published the most extensive preclinical body on tissue-repair effects.
BPC-157TB-500
Synthetic fragment of Thymosin Beta-4. Sequesters actin monomers and facilitates cell migration — the molecular event underlying tissue regeneration in joint, dermal, cardiac, and neural models.
TB-500BPC / TB-500 5mgBlend
The benchmark 5mg recovery protocol pairing BPC-157's angiogenic and gastrointestinal repair effects with TB-500's systemic tissue regeneration. Our most-prescribed post-procedure recovery stack.
BPC / TB-500 5mg BlendBPC / TB-500 15mgBlend
Higher-dose 15mg variant of the BPC/TB stack. Reserved for post-surgical recovery, chronic joint pathology, or athletes returning from significant tissue injury — used selectively under physician oversight.
BPC / TB-500 15mg BlendTB / BPC / KPV / GHKQuad
A four-peptide formulation engineered for clients with both healing and aesthetic concerns: tissue repair (BPC+TB), gut anti-inflammatory signaling (KPV), and dermal collagen stimulation (GHK-Cu).
TB / BPC / KPV / GHK Quad BlendLL-37
Human cathelicidin antimicrobial peptide. Studied for biofilm disruption, immune modulation, and chronic wound healing — particularly relevant in tick-borne illnesses and treatment-resistant infections.
LL-37BPC-157 OralOral
Stabilized oral capsule formulation of BPC-157 with enteric protection. Preferred when targeting gastrointestinal lining specifically, or when patients prefer to avoid injection routes.
BPC-157 OralIncretin Mimetics & Metabolic Optimization
From targeted lipolytic HGH fragments to dual incretin receptor agonists, these compounds address appetite signaling, insulin sensitivity, gastric emptying, and energy expenditure — the molecular machinery of durable weight reduction.
AOD-9604
The C-terminal fragment of human growth hormone (residues 176-191). Retains GH's lipolytic activity without engaging IGF-1 or glucose pathways — fat metabolism without systemic GH load.
AOD-9604Semaglutide S5
Entry-tier GLP-1 receptor agonist concentration. Allows the gentlest titration curve for patients beginning weight management — designed to acclimate the GI system to incretin signaling.
Semaglutide S5Semaglutide S10
Mid-dose semaglutide concentration, the most-prescribed tier for patients with established tolerance. Provides meaningful appetite regulation and weight reduction at a sustainable clinical cadence.
Semaglutide S10Semaglutide S20
Maintenance-grade semaglutide concentration. Equivalent steady-state delivery to brand-name Wegovy 2.4mg/week. Used for long-term metabolic maintenance with documented cardiovascular benefit per the SELECT trial.
Semaglutide S20Tirzepatide
Novel dual incretin receptor agonist activating both GIP and GLP-1 pathways. SURMOUNT trials demonstrated up to 22.5% mean body-weight reduction at 72 weeks — superior to any single-agonist GLP-1.
TirzepatideCagrilintideComing Soon
Long-acting amylin analogue under clinical development. Modulates appetite via the area postrema and slows gastric emptying. Synergistic potential alongside GLP-1 agonists — coming soon.
CagrilintideTesofensineComing Soon
Investigational triple monoamine reuptake inhibitor (serotonin/norepinephrine/dopamine). Studied for combined appetite suppression and increased resting energy expenditure — a different mechanism from incretins.
TesofensineNootropic Signaling & Sleep Architecture
Peptides studied for their ability to cross the blood-brain barrier and modulate BDNF, GABAergic signaling, synaptogenesis, and delta-wave sleep — supporting cognitive performance without the dependence profile of stimulant nootropics.
Dihexa
Hepatocyte growth factor (HGF) potentiator derived from angiotensin IV. In preclinical models drives synaptogenesis at concentrations seven orders of magnitude lower than BDNF itself.
DihexaSemax
Synthetic ACTH(4-10) analogue developed in Russia. Crosses the blood-brain barrier intranasally and upregulates BDNF/NGF expression. Used clinically in Russia for stroke and cognitive disorders since the 1990s.
SemaxSelank
Heptapeptide derivative of the immunomodulator tuftsin. Modulates GABAergic and serotonergic signaling for anxiolytic effect without sedation — designed as a non-benzodiazepine anxiety compound.
SelankDSIP
Delta Sleep-Inducing Peptide, an endogenous nonapeptide. Studied for normalization of delta-wave architecture and modulation of the HPA stress axis — supports restorative sleep rather than sedation.
DSIPDSIP / SelankBlend
Sleep-architecture support (DSIP) combined with daytime anxiolytic signaling (Selank). The 24-hour stress-management protocol favored by patients in demanding professional environments.
DSIP / Selank BlendSemax / Selank / DSIPBlend
Triple cognitive coverage: BDNF/NGF upregulation (Semax daytime), GABAergic anxiolysis (Selank daytime), and delta-wave sleep restoration (DSIP nighttime). Our most-comprehensive cognitive prescription.
Semax / Selank / DSIP Blend5-Amino-1MQOral
Small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Increases intracellular NAD+ pools and methyl donors in adipocytes. Oral capsule with metabolic and cognitive applications.
5-Amino-1MQVitality & Hormonal Axis Support
Centrally and peripherally acting peptides studied for libido, arousal, GnRH and gonadotropin signaling, and the relational neurochemistry of oxytocin — for both men and women, only prescribed after a thorough medical evaluation.
PT-141 (Bremelanotide)
Cyclic heptapeptide melanocortin agonist. FDA-approved as Vyleesi for premenopausal HSDD. Acts centrally on MC3R/MC4R rather than through vascular pathways — works regardless of underlying cause.
PT-141 (Bremelanotide)Kisspeptin
Kiss1 gene product. Upstream of GnRH in the hypothalamic-pituitary-gonadal axis — effectively the master regulator that turns puberty on and reproductive cycling on/off.
KisspeptinGonadorelin
Synthetic decapeptide identical to native GnRH. Used during testosterone replacement therapy to maintain testicular size, intratesticular testosterone, and fertility-preserving function.
GonadorelinOxytocin
Hypothalamic nonapeptide synthesized in the paraventricular and supraoptic nuclei. Modulates pair-bonding, trust, cortisol response, and orgasm physiology. Prescribed sublingually or by injection.
OxytocinImmune Modulation & Cellular Energy
Thymic peptides, mitochondrial signalers, antimicrobials, and the essential coenzyme NAD+ — studied for T-cell regulation, innate immune balance, AMPK activation, and the cellular energy systems that decline measurably with age.
Thymosin Alpha-1
28-amino-acid thymic peptide first isolated by Goldstein. Modulates T-cell maturation and dendritic cell function. Approved internationally (Zadaxin) for chronic hepatitis and immune dysfunction conditions.
Thymosin Alpha-1KPV
The C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH. Despite its small size, retains potent anti-inflammatory activity — investigated in inflammatory bowel disease, atopic dermatitis, and psoriasis models.
KPVKPV / TA-1 / LL-37Blend
Triple immune protocol: anti-inflammatory tripeptide (KPV), T-cell modulating thymic peptide (Thymosin Alpha-1), and antimicrobial cathelicidin (LL-37). Comprehensive immune-system support.
KPV / TA-1 / LL-37 BlendMOTS-c
Mitochondrial-encoded peptide discovered in 2015 (Lee/Cohen labs). Translocates from mitochondria to nucleus to upregulate AMPK and metabolic-stress response genes — one of the most-studied mito-peptides.
MOTS-cNAD+
Nicotinamide Adenine Dinucleotide. The essential cofactor for sirtuin enzymes (longevity) and PARP enzymes (DNA repair). Tissue concentrations decline measurably with age — restored via IV or subQ delivery.
NAD+KPV OralOral
Enterically-protected oral capsule of KPV. Survives gastric transit to deliver anti-inflammatory tripeptide signaling to the GI tract — used for IBD and gut-permeability indications.
KPV OralSLU-PP-332Coming Soon
Selective ERR (estrogen-related receptor) agonist developed by St. Louis University. Investigational exercise-mimetic — early data shows cardiovascular and metabolic benefits without physical exertion. Coming soon.
SLU-PP-332Different by medical design
There is no shortage of online peptide vendors. There is, however, a meaningful difference between buying a research chemical and being prescribed a clinically supervised protocol. Here is what that difference looks like.
Physician at the Helm
Dr. Ernst von Schwarz is a triple board-certified clinical and academic cardiologist, clinical professor of medicine at UCLA, and a three-decade pioneer in stem cell and regenerative medicine. Every Luxbae protocol is written or reviewed under his direction.
Aesthetic Integration
Our peptides are sequenced around our in-spa procedures — Morpheus8, CO2 resurfacing, PRP, Biologique Recherche — so the molecular and the topical work in concert rather than against each other.
No Preset Packages
Other clinics sell tiers. We don’t. Your protocol is built around your labs and goals, and adjusted at the 6–8-week relab — not pre-loaded onto a credit card before your provider has read your numbers.
Real Compounding Sources
Every peptide is sourced from FDA-registered 503A or 503B compounding pharmacies, with certificates of analysis available on request. No “research chemical” suppliers, no overseas grey-market vials.
Reachable Between Visits
Your medical team is accessible between appointments for questions, side-effect concerns, dosing recalibrations, or sequencing changes around a planned procedure. You won’t be on hold.
Boutique by Design
Luxbae is intentionally small — a single West Hollywood medical spa on Melrose, plus our Glendale location. Your protocol is built and run by the same team, not handed off through five layers of staff.
Four steps, no preset packages
Every patient runs through the same clinical workflow. The only thing that varies is the protocol that comes out of it.
Free Consultation
A complimentary, no-obligation sit-down with our medical team to walk through your goals, current treatments, medications, and full history.
Targeted Labs
Where indicated, baseline labs covering hormones, metabolic, inflammatory, and (for GH-axis patients) IGF-1 and full thyroid. Your protocol is anchored to your numbers.
Custom Protocol
Dose, cadence, and delivery method are tailored to you. Many protocols are designed around your in-spa treatment cadence (Morpheus8, CO2, PRP) for compounded effect.
6–8 Week Refinement
Follow-up labs, dose recalibration, and ongoing direct access to your medical team. Continuity, not a one-time transaction.
Build your protocol with the Luxbae medical team
Your consultation is complimentary. We’ll walk you through which peptides are clinically relevant to your case, what labs we would draw first, and exactly how your protocol would sequence with your aesthetic plan.